CONSIDER EXITING $NUVA (NUVASIVE) RIGHT HERE AT $43.50 AS THE STOCK HAS REACHED OUR TARGET FOT THIS VERY SHORT TERM TRADE

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

OUT OF THE REMAINING $INTC (INTEL) SHORT POSITION WITH A PROFIT

The plan was to keep on lowering the stops and progressively tightening them. As INTC approached $20, it was either…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

RAISE STOPS ON $NUVA (NUVASIVE)

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

TAKE MORE PROFITS ON $INTC (INTEL) SHORT POSITION RIGHT HERE AT $20.56 AND TIGHTEN THE STOPS ON THE REST

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

WOW! FDA AGREES WITH OUR LONGSTANDING ASSESSMENT OF FAMPRIDINE-SR , SHORT SELL $ACOR (ACORDIA) PER OUR PRIOR POST

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

TAKE PARTIAL PROFITS AND TIGHTEN STOP BAND ON $NUVA (NUVASIVE)

Per earlier note we are long on $NUVA from $ Take partial profits right here at $ and tighten the…
Read more »
 

TAKE MORE PARTIAL PROFITS ON $INTC HERE AT $20.88 AND TIGHTEN THE STOP ON THE REST

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

TAKE MORE PARTIAL PROFITS ON $INTC RIGHT HERE AT $21.12 AND TIGHTEN THE STOPS

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

ACOR (ACORDIA) FAMPRIDINE IS NOT A VERY GOOD DRUG EVEN IF IT WORKS AS ADVERTISED

The FDA Peripheral and Central Nervous System Drugs Advisory Committee meets today to review ACOR's Fampridine-SR for improvement of walking…
Read more »
 

SHORT ON INTC (INTEL)

As per our earlier post, we are short on INTC from $ Take partial profits right here at $ and…
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers